Sign inJoin waitlistJoin the waitlist

Michael C. Keefer

Professor (Part-Time) - Department of Medicine, Infectious Diseases · University of Rochester School of Medicine

Credentials: · · ·

History

University of Rochester School of Medicine
Present
University of Rochester School of Medicine
Present

University of Rochester School of Medicine
1987–1990
Cincinnati Children's Hospital Medical Center
1986–1987
Christ Hospital
1984–1986
Christ Hospital
1983–1984
Wright State University Boonshoft School of Medicine
1983

Research

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
New England Journal of Medicine · 2021 · 549 citations
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine
New England Journal of Medicine · 2013 · 480 citations
Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The…
The Journal of Infectious Diseases · 1996 · 387 citations

Juliana McElrath
48 papers
Lawrence Corey
38 papers
Geoffrey Gorse
21 papers
Lindsey Baden
20 papers
Paul Goepfert
18 papers
RB
Robert Belshe
18 papers
MM
Mark Mulligan
16 papers
RD
Raphael Dolin
16 papers
Susan Buchbinder
15 papers
Ian Frank
14 papers
Magdalena Sobieszczyk
13 papers
Jim Kublin
12 papers

Grants

University of Rochester HIV/AIDS Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $25.7M · University of Rochester
2007–2027
Units for HIV/AIDS Clinical Trials Networks
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $9.4M · University of Rochester
2007–2013
University of Rochester Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
Project lead · $1.1M · University of Rochester
2008–2013
HSV-1 Amplicon Vectors for HIV Vaccine Delivery
National Institute of Allergy and Infectious Diseases · P01
Contact PI · $11.6M · University of Rochester
2003–2009

Clinical trials

A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers
Principal investigator · Completed · Phase 1
International AIDS Vaccine Initiative
2009–2011
Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
Principal investigator · Completed · Phase 1
International AIDS Vaccine Initiative
2005–2007
Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults
Principal investigator · Completed · Phase 1
International AIDS Vaccine Initiative
2003–2005
A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy Adults
Study chair · Terminated · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2022–2024